Table 1 Demographic and clinical details

From: Gamma entrainment induced by deep brain stimulation as a biomarker for motor improvement with neuromodulation

 

Patient

Age (y)

Sex

DD (y)

Follow-Up (months)

LEDD (mg)

Electrode

Stim Contact

Recording Contacts

Contacts for chronic stimulation

Gamma Peak DBS-off (Hz)

Entrainment Onset (mA)

UPDRS-III Med Off-Stim Off

UPDRS-III Med On-Stim Off

UPDRS-III Med On-Stim On

Dyskinesia DBS Off/On

WITH FTG DBS-OFF

#1

60–65

f

10

3

775

3389

L2

L1-3

1

77

1.0

22

5

5

No/No

#2

50–55

f

13

6

300

3389

L1

L0-2

1

81

2.0

78

34

23

Mild/Mild

#3

50–55

m

7

3

500

3389

R1

R0-2

1

73

2.5

51

28

22

No/No

#4

60–65

m

15

3

300

3389

R2

R1-3

1

73

2.5

39

11

11

Mild/Moderate

#5

70–75

f

12

12

500

SenSight

R2

R1-3

3

76

2.4

44

17

11

No/Mild

#6

50–55

m

13

12

0

SenSight

L2

L1-3

1,3

84

1.0

43

30

7

No/Moderate

#7

50–55

m

14

3

535

SenSight

L1

L0-2

1

80

2.5

19

15

9

No/No

#8

65–70

f

7

18

275

SenSight

R2a

R1-3

1a,2a

83

1.4

53

43

12

Moderate/Severe

NO FTG DBS-OFF

#9

65–70

m

11

12

1250

3389

L2

L1-3

2

(-)

2.0

54

44

33

No/No

#10

70–75

m

20

12

1000

SenSight

R2b

R1-3

2

(-)

2.8

49

39

31

No/No

#11

70–75

f

7

12

475

SenSight

R1

R0-2

1a,1c

(-)

1.5

29

19

12

No/No

#12

70–75

f

14

12

375

SenSight

R1b

R0-2

0,1

(-)

3.0

51

39

21

No/No

#13

55–60

m

15

12

550

SenSight

R1c

R0-2

1

(-)

2.0

34

27

23

No/No

#14

55–60

m

7

12

350

SenSight

R2a

R1-3

2a,2b,3

(-)

3.7

57

35

11

No/No

#15

65–70

f

7

12

400

SenSight

L2b

L1-3

2b,2c

(-)

2.5

42

35

27

No/No

NO GAMMA

#16

60–65

f

7

3

525

3389

L2

L1-3

2

(-)

(-)

42

26

14

No/No

#17

60–65

f

7

12

0

3389

R2

R1-3

2,3

(-)

(-)

40

28

10

No/No

#18

55–60

m

11

12

200

3389

R1

R0-2

2

(-)

(-)

38

-

9

No/No

#19

65–70

f

11

12

1000

3389

R1

R0-2

0,1

(-)

(-)

67

60

41

No/No

  1. DD Disease duration, LEDD Levodopa equivalent daily-dose.